Indocyanine Green Fluorescence Angiography for Quantitative Evaluation of in Situ Parathyroid Gland Perfusion and Function After Total Thyroidectomy
Overview
Affiliations
Background: Because the fluorescent light intensity on an indocyanine green fluorescence angiography reflects the blood perfusion within a focused area, the fluorescent light intensity in the remaining in situ parathyroid glands may predict postoperative hypocalcemia risk after total thyroidectomy.
Methods: Seventy patients underwent intraoperative indocyanine green fluorescence angiography after total thyroidectomy. Any parathyroid glands with a vascular pedicle was left in situ while any parathyroid glands without pedicle or inadvertently removed was autotransplanted. After total thyroidectomy, an intravenous 2.5 mg indocyanine green fluorescence angiography was given and real-time fluorescent images of the thyroid bed were recorded using the SPY imaging system (Novadaq, Ontario, Canada). The fluorescent light intensity of each indocyanine green fluorescence angiography as well as the average and greatest fluorescent light intensity in each patient were calculated. Postoperative hypocalcemia was defined as adjusted calcium <2.00 mmol/L within 24 hours.
Results: The fluorescent light intensity between discolored and normal-looking indocyanine green fluorescence angiographies was similar (P = .479). No patients with a greatest fluorescent light intensity >150% developed postoperative hypocalcemia while 9 (81.8%) patients with a greatest fluorescent light intensity ≤150% did. Similarly, no patients with an average fluorescent light intensity >109% developed PH while 9 (30%) with an average fluorescent light intensity ≤109% did. The greatest fluorescent light intensity was more predictive than day-0 postoperative hypocalcemia (P = .027) and % PTH drop day-0 to 1 (P < .001).
Conclusion: Indocyanine green fluorescence angiography is a promising operative adjunct in determining residual parathyroid glands function and predicting postoperative hypocalcemia risk after total thyroidectomy.
Croft J, Ainsworth G, Corrigan N, Gordon K, Perry A, Twiddy M BMJ Open. 2025; 15(1):e092422.
PMID: 39890139 PMC: 11784174. DOI: 10.1136/bmjopen-2024-092422.
Lahiri A, Yadav V, Arora V, Sharma P, Dewan A Endocrine. 2025; .
PMID: 39776041 DOI: 10.1007/s12020-024-04158-8.
McEntee P, Greevy J, Triponez F, Demarchi M, Cahill R BJS Open. 2024; 8(5).
PMID: 39468722 PMC: 11518927. DOI: 10.1093/bjsopen/zrae122.
Devgan Y, Mayilvaganan S, Mishra A, Chand G, Agarwal G, Agarwal A Ann Med Surg (Lond). 2024; 86(2):678-688.
PMID: 38333253 PMC: 10849419. DOI: 10.1097/MS9.0000000000001578.
Sobutay E, Cakit H, Terzioglu T Sisli Etfal Hastan Tıp Bul. 2024; 57(4):466-472.
PMID: 38268654 PMC: 10805044. DOI: 10.14744/SEMB.2023.06691.